Sber opens weights of two new flagship MoE models in the GigaChat series — Ultra Preview and Lightning — trained from scratch ...
Coave Therapeutics unveils lead gene therapy program for retinal vascular diseases, powered by first-in-class vector for ...
Successful first human implantation marks a transformational moment in ophthalmology and regenerative medicine Breakthrough marks key clinical milestone for Precise Bio's proprietary ...
The USA TODAY Florida Network's four-person panel determine what eight teams should be in the FHSAA's upcoming Open Division ...
"The world will remember Bernie Parent as a Hall of Fame hockey player, a Stanley Cup champion," said Scott Tharp, president ...
How James Blanchard went from promoting recruits on message boards to being the architect of Texas Tech's big-budget roster ...
But Vanity Fair ’s cover is specifically about leading men, not just the quality of their acting. It’s also understandable ...
Kevin Durant is standing at the free-throw line. It's the closing act of Rockets practice, and the slender 37-year-old is ...
St. Patrick's newly renovated pipe organ will help the Memphis church kick off a yearlong celebration of its 160th ...
To say that the show features the most spectacular musicianship on Broadway undersells the thrill. In addition to a feast of ...
2d
NanoViricides, Inc. Has Filed its Quarterly Report – Subsequent Raise Has Fortified Fiscal Position
SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...
(“Surrozen” or the “Company”) (Nasdaq: SRZN), a biotechnology company pioneering targeted therapeutics that selectively modulate the Wnt pathway, with a focus on severe eye diseases, today announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback